About Earlitec Diagnostics dba EarliPoint Health

EarliPoint Health, formerly EarliTec Diagnostics, is a healthcare AI company dedicated to transforming autism care through innovative, FDA-cleared eye-tracking technology. The company’s core product, the EarliPoint System, is a medical device designed to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children aged 16 months through 95 months (7 years). This tablet-based system utilizes dynamic quantification of social-visual engagement, capturing moment-by-moment looking behavior at a rate of 120 times per second—details imperceptible to the human eye. By analyzing how a child visually engages with social and non-social scenes and comparing these data to those of typically developing peers, the system provides objective, quantifiable information.

For physicians, the EarliPoint System offers a significant advancement in early autism identification and ongoing assessment. It generates detailed reports with a focus-area heat map and scores for language, cognition, and social engagement, which support early detection and help track progress over time. This technology aims to reduce the lengthy diagnostic wait times often faced by families and to provide objective insights that complement a clinician’s observation and judgment during the diagnostic process. The system is administered by a technician, with results reviewed and interpreted by a qualified clinician, potentially doubling monthly patient volume and cutting evaluation time by 50%. EarliPoint Health’s mission is to empower providers, families, and health systems with earlier answers and better outcomes, ensuring access to timely, science-based insights for personalized intervention.

Focus Areas

Autism Spectrum Disorder (ASD) diagnosis early intervention eye-tracking technology objective measurement developmental assessment

Business Intelligence

Key InvestorsSocial Innovation Ventures, Clarevia Ventures, Serial Stage Venture Partners, GRA Venture Fund, Nexus NeuroTech Ventures, Venture Investors Health Fund, Bernie Marcus (The Marcus Foundation)
PartnershipsNetsmart, Zest Pediatric Network, AutismTesting4Kids (AT4K), Hopebridge
Acquisitionsunknown
TechnologyCloud-native, eye-tracking technology, AI operating system, digital biomarkers, Dynamic Quantification of Social-Visual Engagement (DQSVE)
FDA Clearances1 (EarliPoint System, with expanded age indications) cleared products (estimated)

What Physicians Need to Know

Specialization: Autism Spectrum Disorder (ASD) Diagnosis & Assessment
EarliPoint Health specializes in aiding qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children aged 16 months to 95 months (7 years) who are at risk.
Core Technology: Eye-Tracking
Their primary technology involves advanced eye-tracking to measure how a child visually engages with social and non-social scenes, capturing moment-by-moment visual-attention biomarkers.
Objective Measurement
The EarliPoint System provides objective, quantifiable information by analyzing visual-attention data with algorithms developed through years of developmental research. This complements a clinician's observation and judgment.
Early Intervention Focus
The company's mission is to transform access to autism care through research-based clinical innovation, enabling earlier understanding and more informed intervention.
Developmental Assessment
The system measures social attention patterns that are recognized biomarkers of ASD and provides EarliPoint Severity Indices that correlate with levels of social disability, verbal ability, and non-verbal learning.
Physician Tip

For physicians, EarliPoint Health offers an FDA-cleared medical device that provides objective, data-driven insights to aid in the diagnosis and assessment of ASD, particularly in young children (16 months to 7 years). This can lead to earlier diagnosis, which is crucial for timely intervention and potentially improved lifelong outcomes. The system is designed for clinical use only and generates same-day reports, streamlining the diagnostic process and helping to reduce wait times. It complements traditional diagnostic tools by offering technology-based measures that enhance consistency and speed, while maintaining diagnostic rigor. EarliPoint Health also provides educational resources for clinicians, including webinars and on-demand content.

The EarliPoint System is a tablet-based eye-tracking assessment system. It integrates into clinical workflows to provide objective, repeatable metrics for diagnostic assessment and outcome tracking. The company is also building the 'EarliPoint Network' to connect families with qualified provider partners, suggesting a focus on network integration and partnerships to expand access to their technology.

Products by Earlitec Diagnostics dba EarliPoint Health

No products listed for this company yet. Know of one? Suggest it →

Reviews & Opinions

No web reviews on file yet for Earlitec Diagnostics dba EarliPoint Health. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about Earlitec Diagnostics dba EarliPoint Health.

Loading videos...

Videos load interactively. If none appear, search YouTube for Earlitec Diagnostics dba EarliPoint Health →

View all on YouTube

Press & Coverage

Netsmart
EarliPointu2122 Health and Netsmart Partner to Expand Reach of Groundbreaking Autism Assessment Technology
Netsmart and EarliPoint Health announced a partnership to make EarliPoint Health's FDA-cleared eye-tracking technology for early autism assessment available to Netsmart's community of autism and IDD organizations. This collaboration aims to equip providers with groundbreaking technology for early identification and intervention, streamlining the diagnostic process and reducing administrative burden.
2026-04
EarliPoint Health
EarliPoint Receives FDA Clearance to Expand Autism Diagnosis and Assessment Up to 8
EarliPoint Health received FDA clearance to expand the age indication for its EarliPoint System, allowing it to aid in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children ages 16 months through 95 months (7 years). This expansion aims to broaden access to objective, biomarker-based autism assessment and enable the measurement of outcomes over time.
2026-03
WBOC (Press Release)
EarliPoint Health and Autism Testing 4 Kids Partner to Expand Access to Timely, Insurance-Friendly Autism Evaluations Nationwide
EarliPoint Health partnered with Autism Testing 4 Kids (AT4K) to expand access to timely and insurance-friendly autism evaluations nationwide. This collaboration allows autism providers using EarliPoint to leverage AT4K's network of licensed psychologists to increase diagnostic capacity.
2026-07
EarliPoint Health
EarliPoint Health Launches Project ALIGN to Advance Objective Measurement and Outcomes in Autism Care
EarliPoint Health launched Project ALIGN (Autism Longitudinal Insights and Growth Network), a consortium of leading autism service providers focused on advancing the use of objective developmental measurement throughout the autism care journey. The project aims to integrate objective insights into clinical workflows to improve care delivery and establish next-generation outcomes measurement.
2026-07
Newsfile Corp.
EarliPoint Health and Zest Pediatric Network Partner to Expand Access to Autism Evaluations and Eliminate Diagnostic Wait Times
EarliPoint Health announced a strategic partnership with Zest Pediatric Network to expand access to timely autism evaluations and eliminate long wait times for families. This collaboration aims to increase diagnostic capacity nationwide through community-based testing and virtual pediatrician review.
2026-06
EarliPoint Health
EarliTec Diagnostics Rebrands as EarliPoint Health, Signaling New Vision for Autism Care
EarliTec Diagnostics rebranded as EarliPoint Health, signifying a new vision for autism care and a bold new chapter in the company's mission to transform autism care.
2025-10
EarliPoint Health
EarliTec Diagnostics, Inc. Raises $21.5 Million in Series B Financing; Funds to Accelerate Commercialization of EarliPoint Evaluation and Further Product Development
EarliTec Diagnostics, Inc. secured $21.5 million in Series B financing, led by Nexus NeuroTech Ventures and Venture Investors Health Fund. The funds are designated to accelerate commercialization efforts and advance clinical research for the EarliPointu2122 Evaluation, an FDA-authorized tool for autism diagnosis and assessment.
2024-04
EarliPoint Health
JAMA Publishes Two Large Studies Demonstrating the Diagnostic Accuracy of EarliTec's Evaluation for Autism in Children as Young as 16 Months
The Journal of the American Medical Association (JAMA) published positive results from a Phase III trial demonstrating the EarliPointu2122 Evaluation's effectiveness and accuracy in aiding autism diagnosis and assessment in children aged 16 to 95 months. The studies showed high diagnostic performance and correlation with gold standard measures of severity and ability.
2023-09

Frequently Asked Questions

EarliPoint Health utilizes eye-tracking technology to objectively measure a child's visual attention to social versus non-social information. This approach provides an objective and quantitative assessment of social visual engagement, which is often atypical in children with ASD, aiding in earlier and more accurate diagnosis.
By providing an objective and earlier diagnosis of ASD, EarliPoint Health's technology allows for the initiation of interventions at a younger age. Early intervention has been shown to significantly improve developmental outcomes for children with ASD, making timely diagnosis crucial.
EarliPoint Health offers the EarliPoint ASD, a device that uses eye-tracking to analyze a child's looking patterns while they watch short videos. This analysis provides an objective measure of a child's social visual engagement, which is then compared to a normative database to aid in the diagnosis of ASD.
While specific pricing details may vary, EarliPoint Health generally offers its diagnostic solutions through a service model. They provide comprehensive support, including training for clinical staff, technical assistance, and ongoing educational resources to ensure effective integration and utilization of their technology.
EarliPoint Health is committed to compliance with all relevant healthcare regulations, including HIPAA for patient data privacy and FDA clearance for its medical devices. The company focuses on robust clinical validation and strategic partnerships to ensure long-term stability and continued innovation in the field of early ASD diagnosis.

Related Companies

Intelligent Voice AI (IVAI) is an agentic AI platform that deploys AI voice agents specifically designed for healthcare, insurance, legal, and home services businesses. For physicians and medical practices, IVAI’s Evolve AI Agents act as an AI workforce, not just an answering service, handling a comprehensive range of administrative and operational tasks. These agents can […]

Dext, formerly known as Receipt Bank, is a company that specializes in bookkeeping automation, leveraging data, technology, and applied AI to enhance productivity and efficiency for businesses, accountants, and bookkeepers. [3, 16] Their platform is designed to streamline financial document management and automate bookkeeping tasks, aiming to simplify the accounting process and enable more informed […]

Cortex (https://www.cortex.app) is an AI-powered internal developer portal designed to enhance engineering excellence and streamline software development workflows. For physicians, this translates to a platform that can indirectly improve healthcare technology by enabling engineering teams to build more reliable, secure, and efficient software. The platform helps in cataloging, scoring, and assigning actions to improve service […]

Nino is an AI-powered financial planning and tax service that aims to provide comprehensive financial guidance. For physicians, Nino’s AI software can help manage income, student loans, and plan career transitions, such as moving from training to practice or considering practice ownership. The platform allows physicians to view loans, income, and savings in one place, […]

Coral AI is a healthcare artificial intelligence company that aims to streamline administrative workflows for healthcare providers, ultimately accelerating patient access to care. The company’s AI-driven platform integrates with existing healthcare systems, including EHRs, fax lines, and payer portals, to automate complex administrative tasks. This includes patient intake, prior authorizations, billing, compliance, and patient outreach. […]

SamaCare is a healthcare AI company that provides a cloud-based workflow intelligence platform designed to streamline the prior authorization process for specialty medications. The company’s platform aims to reduce the administrative burden on medical practices, improve approval rates, and add predictability to patient care. By digitizing the often manual and paper-heavy prior authorization process, SamaCare […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.